DMRA

Damora Therapeutics, Inc. Common Stock
DMRA

19 hedge funds and large institutions have $175M invested in Damora Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$60.9M
2
+$37.2M
3
+$32M
4
SCM
Soleus Capital Management
Connecticut
+$22.5M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$19.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$51.2M
2
$31.2M
3
$26.5M
4
$18.9M
5
$15.9M
6
$8.19M
7
$5.85M
8
$4.67M
9
$4.22M
10
$2.59M
11
$1.67M
12
$1.05M
13
$875K
14
$806K
15
$515K
16
$250K
17
$250K
18
$56K
19
$13K